Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT01135472
PHASE1

Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy Volunteers

Sponsor: City of Hope Medical Center

View on ClinicalTrials.gov

Summary

This dose response study is proposed to explore the extent to which Nexium increases endogenous gastrin concentrations and to assess whether Nexium treatment may be useful in the setting of islet cell transplantation for type 1 diabetes to expand islet cells in vivo after transplant.

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2010-07-13

Completion Date

2012-04-01

Last Updated

2026-10-19

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Esomeprazole Magnesium

NEXIUM 40MG ONCE DAILY FOR 7 DAYS WITH A 2 WEEK WASHOUT PERIOD, NEXIUM 40MG TWICE DAILY WITH A 2 WEEK WASHOUT PERIOD, NEXIUM 80MG TWICE DAILY WITH A 2 WEEK WASHOUT PERIOD.

Locations (1)

City of Hope Medical Center

Duarte, California, United States